DurgicalDurgical
EN
Open the app

Myeloid colony-stimulating factors !

Recombinant G-CSF and GM-CSF that speed neutrophil recovery after chemotherapy or a marrow transplant, lowering the risk of infection.

Updated 2026-11-01

What they are

Filgrastim and pegfilgrastim (G-CSF) act on the neutrophil line; sargramostim (GM-CSF) acts more broadly on granulocytes and monocytes. They are used to prevent febrile neutropenia when the risk from chemotherapy is high, in severe chronic neutropenia, after stem cell transplantation and to mobilise stem cells for collection.

Mechanism of action

They bind cytokine receptors on myeloid progenitors and, through JAK–STAT signalling, increase their proliferation, maturation and release, and activate mature neutrophils.

Target: G-CSF and GM-CSF receptors

Drugs in this class

Others in the class

  • lipegfilgrastim
  • plerixafor (stem cell mobiliser, other mechanism)

Test yourself

Think of the answer, then tap the question to see it.

Which cell line does G-CSF mainly stimulate?

Neutrophils.

What is the commonest adverse effect of filgrastim?

Bone pain.

Why is pegfilgrastim not given on the day of chemotherapy?

Dividing myeloid cells stimulated by it would be more sensitive to the cytotoxic drugs.

Add to my cards (3)

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 45 (McGraw Hill, 2023); Farmacología básica y clínica (Katzung), 16.ª ed., cap. 33 (McGraw Hill, 2025); Filgrastim Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); eEML - Electronic Essential Medicines List (World Health Organization, 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.